• Something wrong with this record ?

Aktuálne postupy u pacientov so zlomeninami proximálneho femuru užívajúcich protidoštičkovú a antikoagulačnú liečbu
[Current Management of Patients with Proximal Femur Fractures Receiving Antiplatelet and Anticoagulant Therapy]

B. Šteňo, A. Bátorová, D. Jankovičová, T. Prigancová, J. Hložník, A. Švec, I. Chandoga

. 2024 ; 91 (5) : 257-263. [pub] -

Language Slovak Country Czech Republic

Document type Journal Article, Review, English Abstract

Digital library NLK
Source

E-resources Online

NLK Free Medical Journals from 2006

Proximal femur fractures (PFF) pose a major challenge in elderly patients with severe comorbidities and receiving antithrombotic therapy since according to the latest guidelines the surgery should be performed as soon as possible, preferably within 24 hours, to reduce mortality and morbidity. This review outlines the practical approach to surgical management of PFF that relies on increasing evidence of safety of early surgery in patients with PFF receiving antiplatelet and anticoagulant therapy. We have also used information from the existing evidence-based guidelines for elective/planned surgery in patients with antithrombotic therapy. The practical approach can be summarised as follows: • Antiplatelet therapy - discontinuation of acetylsalicylic acid (ASA) and clopidogrel in monotherapy or in combination is not necessary prior to surgery. In case of bleeding, antifibrinolytic therapy is recommended as well as administration of platelet concentrate which is rarely needed. • In patients taking warfarin, reversal of its effects is recommended by early administration of vitamin K to allow surgery to be performed within 24 hours. Prothrombin complex concentrate (PCC) as a second-line drug is reserved for extreme cases only. Warfarin therapy is resumed 24 hours after surgery. • Direct oral anticoagulants must be discontinued 24-48 hours prior to surgery, possibly longer depending on the type of drug, time of administration of the last dose, and renal function. In extreme cases, an antidote (idarucizumab, off-label andexanet) can be administered prior to surgery, or PCC in case they are unavailable. Anticoagulation therapy is resumed in 24-48 hours. • Neuraxial anaesthesia is possible when ASA is taken by the patient and in case of effective warfarin reversal. • In early surgery and rapid restart of anticoagulant therapy, bridging therapy with LMWH is not indicated except for in cases with extreme risk of thrombosis. Key words: proximal femur fracture, antiplatelet therapy, anticoagulant therapy, perioperative management.

Current Management of Patients with Proximal Femur Fractures Receiving Antiplatelet and Anticoagulant Therapy

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24022782
003      
CZ-PrNML
005      
20250218134132.0
007      
ta
008      
241205s2024 xr f 000 0|slo||
009      
AR
024    7_
$a 10.55095/ACHOT2024/041 $2 doi
035    __
$a (PubMed)39496190
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a slo $b eng
044    __
$a xr
100    1_
$a Šteňo, Boris $u II. ortopedicko-traumatologická klinika Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava $7 xx0112158
245    10
$a Aktuálne postupy u pacientov so zlomeninami proximálneho femuru užívajúcich protidoštičkovú a antikoagulačnú liečbu / $c B. Šteňo, A. Bátorová, D. Jankovičová, T. Prigancová, J. Hložník, A. Švec, I. Chandoga
246    31
$a [Current Management of Patients with Proximal Femur Fractures Receiving Antiplatelet and Anticoagulant Therapy]
520    9_
$a Proximal femur fractures (PFF) pose a major challenge in elderly patients with severe comorbidities and receiving antithrombotic therapy since according to the latest guidelines the surgery should be performed as soon as possible, preferably within 24 hours, to reduce mortality and morbidity. This review outlines the practical approach to surgical management of PFF that relies on increasing evidence of safety of early surgery in patients with PFF receiving antiplatelet and anticoagulant therapy. We have also used information from the existing evidence-based guidelines for elective/planned surgery in patients with antithrombotic therapy. The practical approach can be summarised as follows: • Antiplatelet therapy - discontinuation of acetylsalicylic acid (ASA) and clopidogrel in monotherapy or in combination is not necessary prior to surgery. In case of bleeding, antifibrinolytic therapy is recommended as well as administration of platelet concentrate which is rarely needed. • In patients taking warfarin, reversal of its effects is recommended by early administration of vitamin K to allow surgery to be performed within 24 hours. Prothrombin complex concentrate (PCC) as a second-line drug is reserved for extreme cases only. Warfarin therapy is resumed 24 hours after surgery. • Direct oral anticoagulants must be discontinued 24-48 hours prior to surgery, possibly longer depending on the type of drug, time of administration of the last dose, and renal function. In extreme cases, an antidote (idarucizumab, off-label andexanet) can be administered prior to surgery, or PCC in case they are unavailable. Anticoagulation therapy is resumed in 24-48 hours. • Neuraxial anaesthesia is possible when ASA is taken by the patient and in case of effective warfarin reversal. • In early surgery and rapid restart of anticoagulant therapy, bridging therapy with LMWH is not indicated except for in cases with extreme risk of thrombosis. Key words: proximal femur fracture, antiplatelet therapy, anticoagulant therapy, perioperative management.
650    _2
$a lidé $7 D006801
650    12
$a antikoagulancia $x škodlivé účinky $x aplikace a dávkování $x terapeutické užití $7 D000925
650    12
$a inhibitory agregace trombocytů $x škodlivé účinky $x terapeutické užití $7 D010975
650    _2
$a fraktury femuru $x chirurgie $7 D005264
650    _2
$a warfarin $x škodlivé účinky $x terapeutické užití $x aplikace a dávkování $7 D014859
650    _2
$a Aspirin $x škodlivé účinky $x terapeutické užití $x aplikace a dávkování $7 D001241
650    _2
$a fraktury proximálního femuru $7 D000092526
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a anglický abstrakt $7 D004740
700    1_
$a Bátorová, Angelika $u Klinika hematológie a transfuziológie Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava $7 xx0103090
700    1_
$a Jankovičová, Denisa $u Klinika hematológie a transfuziológie Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava $7 xx0259636
700    1_
$a Prigancová, Tatiana $u Klinika hematológie a transfuziológie Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava $7 xx0230129
700    1_
$a Hložník, J $u Oddelenie anesteziológie a intenzívnej medicíny, Nemocnica Sv. Cyrila a Metoda, Univerzitná nemocnica Bratislava
700    1_
$a Švec, Andrey $u I. ortopedicko-traumatologická klinika Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava $7 xx0099792
700    1_
$a Chandoga, Ilja, $u II. ortopedicko-traumatologická klinika Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava $d 1977- $7 xx0262786
773    0_
$w MED00011021 $t Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca $x 0001-5415 $g Roč. 91, č. 5 (2024), s. 257-263
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39496190 $y Pubmed
910    __
$a ABA008 $b A 8 $c 507 $y p $z 0
990    __
$a 20241205 $b ABA008
991    __
$a 20250218134128 $b ABA008
999    __
$a ok $b bmc $g 2270201 $s 1234787
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 91 $c 5 $d 257-263 $e - $i 0001-5415 $m Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca $n Acta Chir Orthop Traumatol Cech $x MED00011021
LZP    __
$b NLK138 $a Pubmed-20241205

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...